Magnetar Financial LLC Glaukos Corp Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $1.89 Million - $2.39 Million	24,798 New	24,798 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $187,078 - $233,609	3,994 New	3,994 $213,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $175,569 - $482,352	-6,877 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$54.18 - $65.64 $372,595 - $451,406	6,877 New	6,877 $375,000

349

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.43B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.